Actively Recruiting
iVS-1 Probiotic Intervention Targeting Biological Aging in Midlife Adults
Led by Synbiotic Health · Updated on 2026-04-22
80
Participants Needed
1
Research Sites
47 weeks
Total Duration
On this page
Sponsors
S
Synbiotic Health
Lead Sponsor
M
MusB Research
Collaborating Sponsor
AI-Summary
What this Trial Is About
This study is a randomized, double-blind, placebo-controlled clinical trial designed to evaluate the effects of Bifidobacterium adolescentis (iVS-1) supplementation on biological aging markers, metabolic health, and functional health outcomes in midlife adults. The study explores whether modulation of aging-related biological pathways through the gut microbiome may influence health-related outcomes.
CONDITIONS
Official Title
iVS-1 Probiotic Intervention Targeting Biological Aging in Midlife Adults
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Aged 40 to 75 years
- Body mass index (BMI) between 20 and 34.9 kg/m²
- Able and willing to provide informed consent and participate for the full study duration
You will not qualify if you...
- History of chronic diseases including liver, kidney, or heart conditions
- Currently pregnant or breastfeeding
- Colonoscopy or colonoscopy preparation within 4 weeks before screening
- Planning to have children during the study period
- Current use of probiotics, prebiotics, or metabolic-altering supplements
- Unable to cooperate with study investigators or testing procedures
- Known history of cancer or ongoing cancer treatments
- Abuse of drugs, alcohol, tobacco, nicotine, or other substances
- History of cardiac diseases such as atherosclerosis, heart failure, or angina
- History of chronic or major gastrointestinal diseases or intestinal surgeries
- Diagnosis of type 1 or type 2 diabetes mellitus
- Poorly controlled chronic diseases like hypertension or hyperlipidemia that are clinically unstable
- Vulnerable groups including clinically ill, mentally ill, cognitively impaired, minors, or illiterate individuals
- Significant weight loss greater than 20% in the past month
- Any condition affecting safety or study outcome integrity
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
MusB Research LLC
New Port Richey, Florida, United States, 34638
Actively Recruiting
Research Team
S
Shalini Jain, PhD
CONTACT
I
Indushekar Manjunatha
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
TRIPLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
BASIC_SCIENCE
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here